SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-22-075299
Filing Date
2022-11-25
Accepted
2022-11-28 09:03:43
Documents
2
Period of Report
2022-11-25

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea169260-pre14a_allarity.htm PRE 14A 562879
2 GRAPHIC image_001.jpg GRAPHIC 3680
  Complete submission text file 0001213900-22-075299.txt   569104
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41160 | Film No.: 221421214
SIC: 2834 Pharmaceutical Preparations